SEC Form 4 · accession 0001415889-17-000476
Echo Therapeutics, Inc. · ECTE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shepard M Goldberg
Director
Period of report
Mar 21, 2017
Accepted (ET)
Mar 23, 2017 · 12:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001031927
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.01F1 | Mar 21, 2017 | A | 25,000 | $0.00 | A | 32,250 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted shares granted pursuant to the Issuer's 2008 Equity Incentive Plan which vested in full on the date of grant.